Mereo BioPharma Group PLC (MREO)
3.67
-0.01
(-0.27%)
USD |
NASDAQ |
Nov 22, 14:59
Mereo BioPharma Group Total Liabilities (Quarterly): 16.21M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 16.21M |
| June 30, 2024 | 17.48M |
| March 31, 2024 | 13.10M |
| December 31, 2023 | 15.96M |
| June 30, 2023 | 28.88M |
| December 31, 2022 | 26.01M |
| June 30, 2022 | 46.64M |
| June 30, 2022 | 46.64M |
| December 31, 2021 | 51.85M |
| June 30, 2021 | 88.90M |
| June 30, 2021 | 88.90M |
| December 31, 2020 | 106.19M |
| June 30, 2020 | 105.29M |
| June 30, 2020 | 105.29M |
| Date | Value |
|---|---|
| December 31, 2019 | 60.57M |
| June 30, 2019 | 60.97M |
| June 30, 2019 | 60.97M |
| December 31, 2018 | 43.78M |
| June 30, 2018 | 45.67M |
| June 30, 2018 | 45.67M |
| December 31, 2017 | 45.75M |
| June 30, 2017 | 20.41M |
| June 30, 2017 | 20.41M |
| December 31, 2016 | 9.264M |
| June 30, 2016 | 13.18M |
| June 30, 2016 | 13.18M |
| December 31, 2015 | 6.102M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
13.10M
Minimum
Mar 2024
106.19M
Maximum
Dec 2020
54.53M
Average
46.64M
Median
Jun 2022
Total Liabilities (Quarterly) Benchmarks
| NuCana PLC | 20.58M |
| TC BioPharm (Holdings) PLC | 7.807M |
| Biodexa Pharmaceuticals PLC | 6.628M |
| Adaptimmune Therapeutics PLC | 237.45M |
| Bicycle Therapeutics PLC | 165.71M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 88.75M |
| Shareholders Equity (Quarterly) | 72.54M |